Theravance Biopharma holds investor meetings with January 2026 corporate slide deck; no new financials or guidance

Theravance Biopharma, Inc.

Management team conducting one-on-one meetings with analysts and investors in San Francisco from Jan 12-15, 2026.
Slide deck furnished as Exhibit 99.1 contains corporate overview but no material new information beyond prior disclosures.
Filing under Regulation FD; no financial updates, pipeline changes, or guidance adjustments disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.